Outcomes of octogenarians undergoing gastrectomy performed for malignancy

J Surg Res. 2017 Jan:207:1-6. doi: 10.1016/j.jss.2016.08.020. Epub 2016 Aug 12.

Abstract

Background: Studies on perioperative outcomes of octogenarians with gastric cancer are limited by small sample size. Our aim was to determine the outcomes of gastrectomy and the variation of treatments associated with advanced age (≥80 y).

Methods: The National Surgical Quality Improvement Program database was queried from 2005 to 2011. Patients who underwent gastrectomy for malignancy were identified using International Classification of Diseases, Ninth Revision and Current Procedural Terminology codes.

Results: Of 2591 cases, 487 patients were octogenarians (≥80) and 2104 were nonoctogenarians (<80). Overall, 4.9% of patients had disseminated cancer. Octogenarians had higher 30-d mortality (7.2% versus 2.5%, P < 0.01) and more major complications (31.4% versus 25.5%, P < 0.01), though fewer octogenarians underwent total gastrectomy (24.0% versus 43.2%, P < 0.01) and extended lymphadenectomy (10.1% versus 17.4%, P < 0.01) than the nonoctogenarian cohort. On multivariate analysis, age ≥80 y was associated with major complications (OR, 1.3; 95% CI, 1.03-1.6; P = 0.03) and increased mortality (OR, 3.0; 95% CI, 1.9-4.9; P < 0.01).

Conclusions: Advanced age (≥80 y) was associated with worse outcomes in patients undergoing gastrectomy for malignancy. Therefore, careful staging is necessary to reduce unnecessary operations in this population. Furthermore, surgeons must place greater attention on optimizing the octogenarian population before surgery.

Keywords: American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP); Elderly; Gastrectomy; Gastric cancer; Octogenarian.

MeSH terms

  • Age Factors
  • Aged, 80 and over
  • Databases, Factual
  • Female
  • Gastrectomy* / mortality
  • Humans
  • Male
  • Postoperative Complications / epidemiology
  • Risk Factors
  • Stomach Neoplasms / mortality
  • Stomach Neoplasms / surgery*
  • Treatment Outcome